Advanced search
Publication Cover
Expert Review of Medical Devices Volume 7, 2010 - Issue 5
Submit an article Journal homepage
404
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Prostate cancer imaging: what the next decade holds

Tina Islam Center for Molecular Imaging Research, Massachusetts General Hospital, Department of Radiology, 55 Fruit Street, Boston, MA 02114, USA. [email protected]
&
Mukesh G Harisinghani Center for Molecular Imaging Research, Massachusetts General Hospital, Department of Radiology, 55 Fruit Street, Boston, MA 02114, USA
Pages 577-579 | Published online: 09 Jan 2014

References

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J. Clin.59(4), 225–249 (2009).
  • Dall’Era MA, Konety BR, Cowan JE et al. Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer112(12), 2664–2670 (2008).
  • Wright JL, Lange PH. Newer potential biomarkers in prostate cancer. Rev. Urol.9(4), 207–213 (2007).
  • Kelloff GJ, Choyke P, Coffey DS. Prostate Cancer Imaging Working Group. Challenges in clinical prostate cancer: role of imaging. AJR Am. J. Roentgenol.192(6), 1455–1470 (2009).
  • Turkbey B, Albert PS, Kurdziel K, Choyke PL. Imaging localized prostate cancer: current approaches and new developments. AJR Am. J. Roentgenol.192(6), 1471–1480 (2009).
  • Taymoorian K, Thomas A, Slowinski T et al. Transrectal broadband-Doppler sonography with intravenous contrast medium administration for prostate imaging and biopsy in men with an elevated PSA value and previous negative biopsies. Anticancer Res.27(6C), 4315–4320 (2007).
  • Shimofusa R, Fujimoto H, Akamata H et al. Diffusion-weighted imaging of prostate cancer. J. Comput. Assist. Tomogr.29(2), 149–153 (2005).
  • Mazaheri Y, Shukla-Dave A, Hricak H et al. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging – correlation with pathologic findings. Radiology246(2), 480–488 (2008).
  • Kim CK, Park BK, Kim B. Localization of prostate cancer using 3T MRI: comparison of T2-weighted and dynamic contrast-enhanced imaging. J. Comput. Assist. Tomogr.30(1), 7–11 (2006).
  • Bloch BN, Furman-Haran E, Helbich TH et al. Prostate cancer: accurate determination of extracapsular extension with high-spatial-resolution dynamic contrast-enhanced and T2-weighted MR imaging – initial results. Radiology245(1), 176–185 (2007).
  • Kurhanewicz J, Vigneron DB, Hricak H et al. Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology198(3), 795–805 (1996).
  • Scheidler J, Hricak H, Vigneron DB et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging – clinicopathologic study. Radiology213(2), 473–480 (1999).
  • Weinreb JC, Blume JD, Coakley FV et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy – results of ACRIN prospective multi-institutional clinicopathologic study. Radiology251(1), 122–133 (2009).
  • Zakian KL, Sircar K, Hricak H et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology234(3), 804–814 (2005).
  • Coakley FV, Kurhanewicz J, Lu Y et al. Prostate cancer tumor volume: measurement with endorectal MR and MR spectroscopic imaging. Radiology223(1), 91–97 (2002).
  • Yu KK, Scheidler J, Hricak H et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology213(2), 481–488 (1999).
  • Joseph T, McKenna DA, Westphalen AC et al. Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. Int. J. Radiat. Oncol. Biol. Phys.73(3), 665–671 (2009).
  • Cimitan M, Bortolus R, Morassut S et al. [18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients. Eur. J. Nucl. Med. Mol. Imaging33(12), 1387–1398 (2006).
  • Husarik DB, Miralbell R, Dubs M et al. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur. J. Nucl. Med. Mol. Imaging35(2), 253–263 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.